Published in Clin Cancer Res on October 21, 2015
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Autonomic nerve development contributes to prostate cancer progression. Science (2013) 6.11
A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell (2007) 4.43
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer (2006) 4.27
Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol (2013) 3.36
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med (2000) 3.26
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer (2006) 2.67
Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol (2009) 2.01
Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities. Eur Urol (2005) 1.69
Behavioral stress accelerates prostate cancer development in mice. J Clin Invest (2013) 1.52
Neuroendocrine modulation of cancer progression. Brain Behav Immun (2008) 1.51
Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst (2012) 1.50
Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate (2012) 1.33
Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med (2011) 1.32
The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer (2007) 1.29
Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells. Proc Natl Acad Sci U S A (2011) 1.14
Glucocorticoid receptor signaling and prostate cancer. Cancer Lett (2011) 1.13
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate (2004) 1.08
Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol (2006) 1.08
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev (2013) 1.04
Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era. J Urol (2003) 1.02
Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry (2002) 1.01
Corticosteroid-induced chemotherapy resistance in urological cancers. Cancer Biol Ther (2006) 0.97
Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Prostate (2008) 0.92
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagn (2015) 0.87
β-Adrenergic Receptor Signaling in Prostate Cancer. Front Oncol (2015) 0.86
Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Urol Int (2008) 0.86
Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation. BMC Cancer (2014) 0.83
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy. Urol Oncol (2011) 0.80
Dairy intake in relation to prostate cancer survival. Int J Cancer (2017) 0.75
Increased risk for psychiatric disorders immediately before and after cancer diagnosis: A nationwide matched cohort study in Sweden. Psychoneuroendocrinology (2015) 0.75
Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies. Clin Genitourin Cancer (2017) 0.75